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Abstract
Background
Patients with mitral stenosis (MS) are more prone to develop left atrial (LA) thrombus.
This cross-sectional study was conducted to determine the frequency of LA thrombus
on transthoracic echocardiography (TTE) in patients with MS.
Methods
In this study, we included patients diagnosed with MS undergoing TTE at the echocardiography
department of the National Institute of Cardiovascular Disease (NICVD), Karachi, Pakistan. The
severity of MS was classified based on the mitral valve area (MVA) as follows: very severe: MVA
of ≤1.0 cm2; severe: MVA of ≤1.5 cm 2; and mild to moderate: MVA of >1.5 cm 2. The LA
thrombus was observed and noted on TTE.
Results
A total of 256 MS patients were included in this study, out of which 46.5% (119) were male. The
mean age was 33.78 ±11.51 years. MS was classified as mild to moderate in 3.5% of the patients,
severe in 54.3%, and very severe in 42.2%. In 98.8% of the patients, the etiology of MS was
rheumatic. LA thrombus was observed in 25% (64) of the patients and LA smoke was observed
in 12.1% (31). Among other findings, mitral regurgitation (MR) was observed in 17.2% of the
patients, aortic regurgitation (AR) in 5.1%, aortic stenosis (AS) in 4.7%, and tricuspid
regurgitation (TR) in 48.8%. Five (2%) patients had atrial septal defect (ASD), 17.3% had left
ventricular (LV) dysfunction, 15.2% had right ventricular (RV) dysfunction, and vegetation was
seen in 11.8% of the patients. Patients with LA thrombus were found to be associated with the
following conditions on a higher scale compared to those without: decreased ejection fraction
(EF) (52 ±8.5% vs. 54.94 ±6.6%; p: 0.011); RV dysfunction (39.1% vs. 7.3%; p: <0.001); and
presence of associated pathologies (82.8% vs. 43.8%; p: <0.001).
Conclusion
LA thrombus on TTE was detected in a significant number (25%) of patients with MS. It was
also found to be strongly associated with the severity of the disease, reduced EF, RV
dysfunction, and the presence of associated value pathologies.
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Introduction
A significant reduction was witnessed in the prevalence, incidence, and associated fatalities of
rheumatic heart disease (RHD) in high-income countries in the late 20th century [1].
Containment of this fatal, yet preventable, cardiovascular disease can be partly attributed to
improved living standards and widespread use of penicillin G benzathine for the treatment and
prevention of rheumatic fever (RF) [2,3]. Age-standardized global mortality due to RHD
reportedly declined by 47.8% between the years 1990 and 2015 [1]. However, it still remains one
of the major causes of death and disability-adjusted life-years in the low- and middle-income
countries (LMIC) [4,5]. The surging burden of RHD in LMIC can be attributed to poor living
conditions, poor sanitation, overcrowdedness, and inadequate healthcare infrastructure [6,7].
Mitral stenosis (MS) is the most common among the long-term complications of RF in adults,
but it can be congenital in infants too [8]. Patients with MS, especially those with atrial
fibrillation, are more prone to left atrial (LA) thrombus formation [9,10]. The changed anatomy
and enlarged volume of LA, abnormal blood flow into the atrium, abnormal atrial contraction,
decreased mitral valve area (MVA), and impaired endothelial function are the key determinants
of increased risk of thrombus formation in these patients [11]. The presence of LA thrombus is
associated with a threefold increase in the risk of embolic events [12,13]. Along with the
severity of MS, various other predisposing factors for LA thrombus have been described in
various studies, such as advanced age, duration of symptoms, low cardiac output state, and LA
size [14-16].
Although contrast-enhanced MRI scans provide high sensitivity and specificity for the
detection of LA thrombus, due to widespread availability and easy adaptability,
echocardiography is now considered the best available non-invasive modality for its detection
[17]. The accuracy of echocardiography, more specifically transthoracic echocardiography
(TTE), is disputed, especially in cases where the thrombus is formed in LA appendage. In such
cases, transesophageal echocardiography (TEE) has shown higher accuracy and sensitivity [18].
Due to a lack of education, actability, recourses, and awareness about the disease, the majority
of patients in our population tend to present late for treatment, and usually with very severe
conditions. As a consequence, even TTE is able to detect LA thrombus with high accuracy in
such patients. This study was designed to quantify the frequency of LA thrombus on TTE in
patients with MS at a tertiary care cardiac center in Karachi, Pakistan.
Materials And Methods
In this observational study, we included patients undergoing TTE at the echocardiography
department of the National Institute of Cardiovascular Disease (NICVD), Karachi, Pakistan from
September 2018 to January 2019. Inclusion criteria were as follows: both male and female
patients between 15-65 years of age who are diagnosed with MS. Patients with a history of any
prior cardiac surgery or those who were currently on anticoagulation therapy were excluded.
Informed consent was obtained for the TTE along with consent regarding the inclusion of
patients in the study and to use obtained data for research and publications while maintaining
the anonymity of the patient.
The TTE studies were performed by consultant echocardiographers by a standard technique,
and echocardiographic parameters such as MVA, LA size, left ventricular diastolic diameter
(LVDD), left ventricular systolic diameter (LSDD), and aorta diameter were measured as per the
American Society of Echocardiography criteria [19]. MS was classified as very severe if MVA was
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≤1.0 cm2, severe if MVA was ≤1.5 cm 2, and mild to moderate if MVA was >1.5 cm 2. The etiology
of MS was considered rheumatic when commissural fusion and diastolic doming of the mitral
valve leaflets were seen. The LA thrombus was observed and presence was noted on TTE. To
attain the maximum visualization of thrombus, LA was examined in multiple transthoracic
views with angulation of transducer to increase visualization of LA appendage, such as
standard parasternal long axis, subcostal view, apical view, and parasternal short-axis view.
The presence and severity of the associated valve pathologies such as mitral regurgitation (MR),
aortic regurgitation (AR), aortic stenosis (AS), tricuspid regurgitation (TR), and atrial septal
defect (ASD) along with pulmonary artery pressure, ejection fraction (EF), right ventricular (RV)
dysfunction, and presence of vegetation were also recorded. Obtained echocardiographic data
along with patients demographics, such as age and gender, were recorded on a proforma and
entered on to a data entry screen designed using the Census and Survey Processing System
(CSPro) version 7.0. Data analysis processes were carried out using IBM SPSS, Version 21.0.
(IBM Corp., Armonk, NY). Mean ±standard deviation (SD) and frequency were calculated for
continuous and categorical response data respectively. Patients were stratified based on the
presence of LA thrombus, and the appropriate Chi-square test and independent-sample
Student's t-test were performed. A two-sided p-value of ≤0.05 was considered as statistically
significant.
Results
This observational study included a total of 256 patients with MS, out of which 53.5% (137)
were female. The mean age of the cohort was 33.78 ±11.51 years. A significant number of
patients [42.2% (108)] had very severe MS and pathophysiology of MS was rheumatic in 98.8%
(253) of the patients. Thrombus in LA on TTE was observed in 25% (64) of patients and 12.1%
(31) patients had LA smoke. The presence of LA thrombus was found to be significantly
associated with the severity of MS (p: <0.001), which was observed with the frequency of 0%
(0/9), 8.6% (12/139), and 48.1% (52/108) in patients with mild to moderate, severe, and very
severe MS respectively. Gender and age distribution and TTE findings in the study population
are presented in Table 1.






Age, years, mean ±SD 33.78 ±11.51
Up to 40 years, n (%) 197 (77)
41-65 years, n (%) 56 (21.9)
>65 years, n (%) 3 (1.2)
Severity of MS, n (%)
Mild to moderate 9 (3.5)
Severe 139 (54.3)
Very severe 108 (42.2)
LA thrombus, n (%) 64 (25)
LA smoke, n (%) 31 (12.1)
Echocardiographic parameters, mean ±SD, mm
LA size 45.25 ±7.98
LVDD 40.46 ±5.16
LSDD 27.82 ±5.58
Aorta diameter 31.29 ±5.61
TABLE 1: Gender and age distribution and transthoracic echocardiography findings in
the study population
SD: standard deviation; MS: mitral stenosis; LA: left atrial; LVDD: left ventricular diastolic diameter; LSDD: left ventricular systolic
diameter
Among other findings, MR was observed in 17.2% of the patients, AR in 5.1%, AS in 4.7%, and
TR in 48.8%. Five (2%) patients had ASD, 17.3% had LV dysfunction, 15.2% had RV dysfunction,
and vegetation was seen in 11.8% of the patients. Patients with LA thrombus were found to be
associated with the following conditions on a higher scale compared to those without:
decreased EF (52 ±8.5% vs. 54.94 ±6.6%; p: 0.011); RV dysfunction (39.1% vs. 7.3%; p: <0.001);
and the presence of associated pathologies (82.8% vs. 43.8%; p: <0.001). TTE parameters and
associated valve pathologies stratified by the presence of LA thrombus in the study population
are presented in Table 2.
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Total patients 256 64 192 -
Associated valve pathologies, n (%) 137 (53.5) 53 (82.8) 84 (43.8) <0.001
MR, n (%) 44 (17.2) 16 (25) 28 (14.6) 0.056
Mild, n (%) 28 (63.6) 10 (62.5) 18 (64.3)
0.906Moderate, n (%) 16 (36.4) 6 (37.5) 10 (35.7)
Severe, n (%) 0 (0) 0 (0) 0 (0)
AR, n (%) 13 (5.1) 3 (4.7) 10 (5.2) 0.869
Mild, n (%) 12 (92.3) 3 (100) 9 (90)
0.569Moderate, n (%) 1 (7.7) 0 (0) 1 (10)
Severe, n (%) 0 (0) 0 (0) 0 (0)
AS, n (%) 12 (4.7) 5 (7.8) 7 (3.6) 0.172
Mild, n (%) 6 (50) 5 (100) 1 (14.3)
0.014Moderate, n (%) 3 (25) 0 (0) 3 (42.9)
Severe, n (%) 3 (25) 0 (0) 3 (42.9)
TR, n (%) 125 (48.8) 49 (76.6) 76 (39.6) <0.001
Mild, n (%) 37 (29.6) 12 (24.5) 25 (32.9)
0.603Moderate, n (%) 62 (49.6) 26 (53.1) 36 (47.4)
Severe, n (%) 26 (20.8) 11 (22.4) 15 (19.7)
ASD, n (%) 5 (2) 0 (0) 5 (2.6) 0.192
Pulmonary artery pressure, mean ±SD, mmHg 58.72 ±16.2 62.39 ±17.7 57.47 ±15.6 0.083
LV dysfunction, n (%) 44 (17.3) 19 (29.7) 25 (13.1) 0.192
Decreased EF, mean ±SD, % 54.19 ±7.2 52 ±8.5 54.94 ±6.6 0.011
RV dysfunction, n (%) 39 (15.2) 25 (39.1) 14 (7.3) <0.001
Mild, n (%) 23 (59) 13 (52) 10 (71.4)
0.237Moderate, n (%) 16 (41) 12 (48) 4 (28.6)
Severe, n (%) 0 (0) 0 (0) 0 (0)
Vegetation, n (%) 30 (11.8) 7 (10.9) 23 (12.1) 0.802
Anterior mitral leaflet, n (%) 22 (73.3) 7 (100) 15 (65.2)
2020 Ahmed et al. Cureus 12(3): e7453. DOI 10.7759/cureus.7453 5 of 8
Posterior mitral leaflet, n (%) 6 (20) 0 (0) 6 (26.1) 0.19
Others, n (%) 2 (6.7) 0 (0) 2 (8.7)
TABLE 2: Transthoracic echocardiography parameters and associated valve
pathology stratified by the presence of left atrial thrombus in the study population
LA: left atrial; MR: mitral regurgitation; AR: atrial regurgitation; AS: atrial stenosis; TR: tricuspid regurgitation; ASD: atrial septal defect;
SD: standard deviation; LV: left ventricular; EF: ejection fraction; RV: right ventricular
Discussion
LA thrombus in patients with MS is a challenging complication associated with the increased
risk of systemic embolization resulting in higher mortality and morbidity [20,21]. Even though
TEE is the well-established gold standard for the detection of LA thrombus, in our clinical
observation, the majority of patients presented with very severe conditions due to late
presentation, lack of awareness, actability, and limitation of recourses, and hence, even TTE
was able to detect LA thrombus with high accuracy in our population. In this selected cohort,
we observed that a significant number of patients presented with very severe MS (42.2%), and
LA thrombus on TTE was detected in 25%, which is much higher than the reported frequency of
3.8-22.8% in some of the previous regional studies [16,20,22-24]. The pertinent reason for the
higher frequency of LA thrombus in our study could be the higher proportion of patients with
very severe MS. This is evident from our results as they indicated that the severity of diseases is
strongly associated with the presence of thrombus. Also, the association between the severity
of MS and the presence of LA thrombus was indeed reported in one past study [20].
Most of the studies conducted for this population are based on TEE [20,23,24]. Although the
sensitivity and specificity of TTE are disputed, the detection of LA thrombus using LA
enlargement of TTE is reported to be nearly 90% accurate, with a sensitivity of 88.9% and
specificity of 52.2%, based on a study of patients with ischemic stroke [25]. Atrial fibrillation,
smaller LA size, bigger MVA, and no low-flow velocities are also reported to be associated with
LA thrombus [20,23]. In our study, associated valve pathologies such as TR, RV dysfunction, and
reduced EF were found to be associated with LA thrombus.
In the era of percutaneous interventions, a clot in LA is one of the contraindications for
percutaneous balloon mitral valvuloplasty (PBMV) due to the risk of embolism [24].
Guidelines recommend vitamin K antagonists (VKA) such as warfarin or novel anticoagulants
for the resolution of thrombus [26]. Studies have shown the resolution of thrombus after short-
and long-term (three and six months) of anticoagulation [27-29].
A pertinent lack of accuracy, sensitivity, and specificity of TTE in the detection of LA thrombus
and the non-availability of TEE studies due to lack of resources and time are the key limitations
of this study. TTE can be a good screening modality for the assessment of LA thrombus in
resource-limited settings; however, for clinical decision-making for management options, TEE
confirmation should indeed be considered.
Conclusions
Our study was designed to quantify the frequency of LA thrombus on TTE in patients with MS.
In our study, LA thrombus on TTE was detected in a significant number (25%) of the patients
with MS. Additionally, it was found to be strongly associated with the severity of the disease,
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decreased EF, RV dysfunction, and the presence of associated value pathologies.
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